This article was originally published in The Tan Sheet
Supplement/OTC drug manufacturer reaches agreement in principle with lenders to extend forbearance deadline until Sept. 28. Extension enables company to continue push toward permanent financial restructuring plan (1"The Tan Sheet" Aug. 20, p. 9)
You may also be interested in...
Leiner Health Products' ongoing restructuring efforts appear to be paying dividends as the firm's net sales jumped 7.2% to $139.5 mil. for the first quarter ended June 30.
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands